BioAtla, Inc. BCAB
2.07 USD -0.03 -1.43%
As of Nov 2, 3:50 PM ET
- YTD
- -92.71%
- 1 year
- -94.04%
- Open
- 2.11
- Prev close
- 2.10
- Mkt cap
- 3.45M
- Vol
- 310
- Avg vol
- 54.30K
- EPS
- -25.23
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.06
- High
- 2.11
- Forward P/E
- -0.42
- Beta
- 1.02
- Short ratio
- 3.70
- Inst. own
- 42.79%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 1.72
- 200-d avg
- 1.99
- 1y target
- 9.00
1D chart
Chart tools
Chart is warming up
The one-day price history for BCAB has not been loaded yet. Try again in a moment.
Altman Z-Score
-93.50 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.6×
P/S 16.7×
P/B -0.9×
P/FCF -0.7×
EV/EBITDA -0.5×
EV/Sales 16.2×
FCF Yield -144.3%
Gross Margin -2053.7%
Operating Margin -2965.3%
Net Margin -2980.3%
ROE 164.7%
ROIC 889.5%
ROA -431.1%
Revenue -81.8%
Operating Income 19.8%
EPS (diluted) 29.9%
Free Cash Flow 33.0%
Current Ratio 0.4×
Quick Ratio 0.4×
Debt / Equity -0.2×
Net Debt / EBITDA 0.0×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31